Abelacimab substantially lowers bleeding risk compared with rivaroxaban Presented ByDr Christian Ruff, Brigham and Women’s Hospital, USA TrialPhase 2, AZALEA-TIMI 71 ConferenceAHA 2023 TypePeer-reviewed article 29 January 2024 15:22